Jan Dahmén

Title: Jan Dahmén: Innovator in Pharmaceutical Chemistry

Introduction

Jan Dahmén is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on indazolyl derivatives. With a total of 4 patents to his name, Dahmén has established himself as a key figure in the development of new medicinal compounds.

Latest Patents

Dahmén's latest patents focus on phenyl and benzodioxinyl substituted indazoles derivatives. The present invention relates to novel indazolyl derivatives, which include pharmaceutical compositions comprising such derivatives. Additionally, the patents detail processes for preparing these novel derivatives and their use as medicaments. This work highlights his commitment to advancing medical science through innovative chemical solutions.

Career Highlights

Throughout his career, Jan Dahmén has worked with prominent companies in the pharmaceutical industry, including AstraZeneca AB and Bayer Schering Pharma AG. His experience in these organizations has allowed him to contribute to various projects that aim to improve healthcare outcomes through innovative drug development.

Collaborations

Dahmén has collaborated with several professionals in his field, including Markus Berger and Karl Henrik Edman. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Jan Dahmén's contributions to pharmaceutical chemistry through his patents and collaborations underscore his role as an influential inventor. His work continues to pave the way for advancements in medicinal compounds that can benefit society.